Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
69.4 SEK | -3.34% | -1.98% | +12.30% |
Apr. 25 | Transcript : Bactiguard Holding AB, Q1 2024 Earnings Call, Apr 25, 2024 | |
Apr. 25 | Bactiguard Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
Weaknesses
- Low profitability weakens the company.
- One of the major weak points of the company is its financial situation.
- Based on current prices, the company has particularly high valuation levels.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+12.30% | 233M | C- | ||
-29.70% | 3.15B | B- | ||
-15.57% | 2.57B | C+ | ||
+21.75% | 2.55B | - | A- | |
+7.04% | 2.09B | B | ||
-1.13% | 2.04B | - | ||
-0.56% | 1.53B | B | ||
+0.59% | 1.33B | - | ||
+23.78% | 1.23B | C | ||
+4.72% | 1.16B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- BACTI B Stock
- Ratings Bactiguard Holding AB